Psychiatry

Schizophrenia PRS was linked to increased disorganized symptom dimension scores.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

The COVID-19 pandemic may have exposed more disparities based on race or ethnicity in ADHD care.

Higher depressive and manic (symptoms were associated with lower GAF, most strongly among the older participants.

Severe mental disorders had the highest odds ratios for the risk of mortality.

OnabotulinumtoxinA treatment may now include 8 new muscles.

For only reward learning, anhedonia was associated with model-derived learning parameters and neural learning signals.

CBGT and MBSR were both associated with a significant decrease in negative emotion.

On this episode of Coping After COVID, Dr. Craig Chepke discusses the challenges for schizophrenia patients.

Data show total amount of patients pre-guideline was 558,175 compared to 532,962 patients after the release of the guideline.

Researchers found the strongest associations between ADHD and nervous system disorders and respiratory diseases.

There was no evidence found suggesting children with lower emotion regulation ability at years old had greater probability of later reporting symptoms of broad anorexia nervosa.

Methylphenidate hydrochloride (Adhansia XR) was originally approved in 2019 for ADHD patients at least 6 years old.

Younger age and individuals who work more than 41 hours per week were associated with more prevalent mental health symptoms.

Dr. Robert Baillieu discusses how the COVID-19 pandemic has specifically impacted patients dealing with addiction problems.

Data show 37.5% of patients in study were found to have moderate to severe DD, with an average score of ≥2.

Children treated with SSRIs and SGAs concurrently demonstrate higher waist circumference, BMI, and plasma total cholesterol compared to those on monotherapy.

The treatment was well-tolerated with a safety profile consistent with previous clinical trials.

Lamotrigine is currently being used as a maintenance therapy for bipolar disorder.

Viloxazine was approved in April by the FDA for pediatric ADHD patients between 6-17 years old.

The dual orexin receptor antagonist notably demonstrates a positive benefit-risk balance for patients

Suspected suicide attempts have increased more among females.

Baseline eGFR and increasing age were good predictors of eGFR.